Next stop after the EU and Canada could very well be the Asian markets including India.  The article presents a interesting look on India and the prospects of medical technology.  Most of the population could only afford basic healthcare services.  With demographic shifts, Solos' products would become highly successful here.  Cheers!

http://www.deloitte.com/assets/Dcom-India/Loc..._India.pdf